Finally, we describe defects in antigen presentation in FSHD PBMCs indicating a potential role for DUX4 in systemic MHC I expression dynamics and propose transcript-level analysis as a powerful approach to blood based biomarker discovery. Here, DUX4 is linked to facioscapulohumeral muscular dystrophy.